肛肠科疾病患者血清CEA、CA125水平与病情严重程度及ALT、AST相关性分析OA
Correlation between Serum CEA and CA125 Levels and Disease Severity,as well as ALT and AST in Patients with Coloproctological Diseases
目的:本研究旨在系统分析肛肠科疾病患者血清癌胚抗原(CEA)、糖类抗原125(CA125)水平与病情严重程度及谷丙转氨酶(ALT)、谷草转氨酶(AST)的相关性,为临床病情评估和治疗指导提供客观参考指标.方法:选取2022年4月至2025年7月我院收治的120例肛肠科疾病患者作为研究参与者,根据病情严重程度分为轻度组(45例,含轻度痔疮、肛裂)、中度组(40例,含中度痔疮、肛瘘、直肠脱垂)和重度组(35例,含重度痔疮、结直肠癌),所有患者均于入院后第2天清晨空腹采集肘静脉血,采用全自动生化分析仪检测血清ALT、AST水平,采用电化学发光免疫分析仪检测血清CEA、CA125水平,运用SPSS22.0统计学软件进行数据分析,多组间比较采用方差分析,两两比较采用LSD-t检验,相关性分析采用Pearson相关分析.结果:3组患者血清CEA、CA125水平比较差异有统计学意义(P<0.05),轻度组CEA[(5.23±1.56)ng/mL]、CA125[(25.34±8.56)U/mL]水平低于中、重度组,中度组CEA[(8.56±2.13)ng/mL)]、CA125[(35.67±10.23)U/mL)]水平低于重度组CEA[(15.23±3.21)ng/mL]、CA125[(55.45±15.34)U/mL],差异均有统计学意义(P<0.05).3组患者血清ALT、AST水平比较差异有统计学意义(P<0.001),轻度组ALT[(25.34±5.67)U/L)]、AST[(28.45±6.78)U/L)]水平低于中、重度组,中度组ALT[(35.67±8.23)U/L]、AST[(35.78±7.89)U/L]水平低于重度组ALT[(45.23±10.34)U/L、AST[(45.67±10.23)U/L],差异均有统计学意义(P<0.05).Pearson相关分析显示,血清CEA、CA125水平与病情严重程度均呈正相关(r=0.785、0.723,P<0.05),且与ALT、AST水平均呈正相关(CEA与ALT r=0.654、与AST r=0.623;CA125与ALT r=0.587、与AST r=0.556,P均<0.001).结论:血清CEA、CA125水平随肛肠科疾病病情加重而升高,可作为评估病情严重程度的有效参考指标;同时二者与肝脏功能指标ALT、AST存在显著正相关,提示在临床诊疗中需同步关注患者肝脏功能状态,为个体化治疗方案制定及预后判断提供科学依据.
Objective To systematically analyze the correlation between serum carcinoembryonic antigen(CEA)and carbohydrate antigen 125(CA125)levels and the disease severity as well as alanine aminotransfer‐ase(ALT)and aspartate aminotransferase(AST)in patients with coloproctological diseases,so as to provide objective reference indicators for clinical disease assessment and treatment guidance.Methods A total of 120 patients with coloproctological diseases admitted to our hospital from April 2022 to July 2025 were selected as study participants.According to the disease severity,they were divided into the mild group(45 cases,including mild hemorrhoids and anal fissure),moderate group(40 cases,including moderate hemorrhoids,anal fistula and rectal prolapse)and severe group(35 cases,including severe hemorrhoids and colorectal cancer).Fasting elbow venous blood samples of all patients were collected on the second morning after admission.Serum ALT and AST levels were detected by automatic biochemical analyzer,and serum CEA and CA125 lev‐els were measured by electrochemiluminescence immunoassay analyzer.Data analysis was performed using SPSS 22.0 statistical software.Analysis of variance was used for comparison among multiple groups,LSD-t test was applied for pairwise comparison,and Pearson correlation analysis was adopted for correlation analy‐sis.Results There were statistically significant differences in serum CEA and CA125 levels among the three groups(P<0.05).The levels of CEA[(5.23±1.56)ng/mL]and CA125[(25.34±8.56)U/mL]in the mild group were lower than those in the moderate and severe groups.The levels of CEA[(8.56±2.13)ng/mL]and CA125[(35.67±10.23)U/mL]in the moderate group were lower than those in the severe group[CEA:(15.23±3.21)ng/mL,CA125:(55.45±15.34)U/mL],with statistically significant differences(P<0.05).There were statistically significant differences in serum ALT and AST levels among the three groups(P<0.001).The levels of ALT[(25.34±5.67)U/L]and AST[(28.45±6.78)U/L]in the mild group were lower than those in the moderate and severe groups.The levels of ALT[(35.67±8.23)U/L]and AST[(35.78±7.89)U/L]in the moderate group were lower than those in the severe group[ALT:(45.23±10.34)U/L,AST:(45.67±10.23)U/L],with statistically significant differences(P<0.05).Pearson cor‐relation analysis showed that serum CEA and CA125 levels were positively correlated with disease severity(r=0.785,0.723,P<0.05),and also positively correlated with ALT and AST levels(CEA vs ALT:r=0.654;CEA vs AST:r=0.623;CA125 vs ALT:r=0.587;CA125 vs AST:r=0.556,all P<0.001).Conclusion Serum CEA and CA125 levels increase with the aggravation of coloproctological diseases,which can serve as effective reference indicators for evaluating disease severity.Meanwhile,the two indicators are sig‐nificantly positively correlated with liver function indicators of ALT and AST,suggesting that attention should be paid to the liver function status of patients during clinical diagnosis and treatment,so as to provide scientific basis for the formulation of individualized treatment plans and prognosis judgment.
陈海云
信阳市人民医院医学检验科(河南 信阳 464000)
肛肠科疾病癌胚抗原糖类抗原125病情严重程度谷丙转氨酶谷草转氨酶
Coloproctological diseasesCarcinoembryonic antigenCarbohydrate antigen 125Disease severityAlanine aminotransferaseAspartate aminotransferase
《中国肛肠病杂志》 2026 (1)
21-24,4
评论